Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
De Novo Ventures is a venture capital firm founded in 2020 and based in the United States. The firm focuses on building technology companies, particularly in the healthcare sector. De Novo Ventures aims to back winning products and teams that can deliver successful outcomes in healthcare, emphasizing improvements in patient care and financing solutions.
Currently, De Novo Ventures manages a portfolio of eight companies, showcasing its commitment to supporting innovative healthcare technologies. The firm operates with a founder-operator model, which allows it to leverage the expertise of its team, composed of former executives and founders who have successfully navigated exits. This model enables De Novo Ventures to provide strategic guidance and operational support to its portfolio companies.
Located in the United States, De Novo Ventures is positioned to capitalize on the growing demand for healthcare innovations. The firm has established itself as a key player in the healthcare investment space, focusing on early-stage investments that can lead to significant advancements in patient care.
De Novo Ventures invests primarily in technology companies within the healthcare sector, targeting stages from pre-seed to pre-IPO. The firm emphasizes supporting innovations that enhance patient care, financing solutions, and communication technologies. Their investment strategy is designed to identify and back exceptional teams capable of delivering successful results in healthcare technology.
The firm is particularly interested in sectors such as biotech, medical devices, health platforms, and digital health. De Novo Ventures seeks to partner with companies that demonstrate potential for significant impact in these areas. Their check sizes typically align with early-stage funding rounds, allowing them to engage deeply with portfolio companies as they grow.
De Novo Ventures looks for founders who possess a strong vision and the capability to execute their ideas effectively. The firm values collaboration and aims to provide not just capital but also strategic insights and operational support to help companies scale successfully.
De Novo Ventures has invested in a diverse range of companies within the healthcare technology sector. Notable portfolio companies include:
This portfolio reflects De Novo Ventures' commitment to enhancing patient care through innovative technologies and solutions.
Dave Mordaunt, PhD: Managing Director at De Novo Ventures. He has a background in healthcare technology and has previously held executive roles in successful startups. His expertise lies in guiding early-stage companies through growth phases and navigating the complexities of the healthcare market.
To pitch De Novo Ventures, founders should send an email to be.great@denovoventures.com. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team background. Founders should also highlight any traction or milestones achieved to date.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
What are De Novo Ventures' investment criteria?
De Novo Ventures primarily invests in technology companies within the healthcare sector, focusing on early-stage opportunities from pre-seed to pre-IPO. They emphasize innovations that enhance patient care and financing solutions.
How can I pitch to De Novo Ventures?
Founders can reach out via email at be.great@denovoventures.com. It is advisable to include a detailed pitch deck outlining the business model, market opportunity, and team background.
What makes De Novo Ventures different from other VC firms?
De Novo Ventures operates with a founder-operator model, meaning their team consists of former executives and founders who have successfully navigated exits. This experience allows them to provide valuable strategic guidance and operational support to portfolio companies.
What is the geographic focus of De Novo Ventures?
The firm primarily invests in North America, specifically within the United States, but they have a national reach and are open to opportunities that align with their investment thesis.
What stages does De Novo Ventures invest in?
De Novo Ventures invests across various stages, including pre-seed, seed, Series A, Series B, Series C, growth equity, and pre-IPO. This broad range allows them to engage with companies at different points in their development.
What type of support can portfolio companies expect?
Portfolio companies benefit from the expertise of De Novo Ventures' team, which provides strategic guidance, operational support, and access to a network of industry contacts. This support is designed to help companies scale effectively and achieve successful outcomes.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.